Antiplatelet Therapy to Prevent Stroke in African Americans

Completed

Phase 4 Results

Summary of Purpose

The African-American Antiplatelet Stroke Prevention Study is designed to prevent recurrent strokes by administration of aspirin or ticlopidine. The study also provides community information on reducing risk of stroke and recognizing the symptoms of stroke. The study involves more than 50 participating hospitals located throughout the United States. Study medication is provided free of charge, and a...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 June 2005.

Unavailable 25 Feb 2000 Unavailable Unavailable 1 Jun 2003 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention

Contacts

Not available